Details
Stereochemistry | ACHIRAL |
Molecular Formula | I2 |
Molecular Weight | 245.8112 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[123I][123I]
InChI
InChIKey=PNDPGZBMCMUPRI-UBRKOFTGSA-N
InChI=1S/I2/c1-2/i1-4,2-4
Molecular Formula | I2 |
Molecular Weight | 245.8112 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/pro/sodium-iodide-i-123.html
Sources: https://www.drugs.com/pro/sodium-iodide-i-123.html
IODINE I-123 is a radioactive isotope of iodine used in nuclear medicine imaging, including single photon emission computed tomography (SPECT) and X-ray computed tomography (X-Ray CT) scans. Iodine-123 is usually supplied as sodium iodide (NaI) and hypoiodite (OI−) in dilute sodium hydroxide solution, at high isotopic purity. 123I is the most suitable isotope of iodine for the diagnostic study of thyroid diseases. The half-life of approximately 13.13 h (hours) is ideal for the 24-h (hour) iodine uptake test and 123I has other advantages for diagnostic imaging thyroid tissue and thyroid cancer metastasis. The iodine is taken up by the thyroid gland and/or cancer metastasis and a gamma camera is used to functional images of the thyroid for diagnosis. Quantitative measurements of the thyroid can be performed to calculate the iodine uptake (absorption) for the diagnosis of hyperthyroidism and hypothyroidism. This is administered to a patient in capsule form, by intravenous injection, or in a drink.
CNS Activity
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | SODIUM IODIDE I 123 Approved UseINDICATIONS AND USAGE. Administration of Sodium Iodide I 123 Capsules is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. Launch Date1991 |
|||
Diagnostic | SODIUM IODIDE I 123 Approved UseINDICATIONS AND USAGE. Administration of Sodium Iodide I 123 Capsules is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. Launch Date1991 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/pro/sodium-iodide-i-123.html
The recommended oral dose for the average patient (70 kg) is 3.7 to 14.8 MBq (100 to 400 μCi). The lower part of the dosage range 3.7 MBq (100 μCi) is recommended for uptake studies alone, and the higher part 14.8 MBq (400 μCi) for thyroid imaging.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:55:07 GMT 2023
by
admin
on
Fri Dec 15 18:55:07 GMT 2023
|
Record UNII |
8YWR746RPQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2462
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
||
|
NDF-RT |
N0000177914
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10220516
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
8YWR746RPQ
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
C64794
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
SUB14240MIG
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
15715-08-9
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
8YWR746RPQ
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
Iodine-123
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
100000090518
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
75501-15-4
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
SUPERSEDED | |||
|
2052213-29-1
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY | |||
|
DTXSID60895055
Created by
admin on Fri Dec 15 18:55:07 GMT 2023 , Edited by admin on Fri Dec 15 18:55:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
NON-LABELED -> LABELED |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |